AstraZeneca sells rights for Seroquel to Luye Pharma for $538 million
LONDON (Reuters) - British pharma company AstraZeneca said it had sold the rights for Seroquel, a treatment for schizophrenia and bipolar disease, to Luye Pharma Group for $538 million, as part of a strategy to focus on other therapy areas.
from Reuters: Health News https://reut.rs/2K1W0dG
http://bit.ly/2zwRqiM